Nirav Vora, MD
Neurology · Columbus, OHNPI 1033254636
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,450 of the $21,486 with a category attached, or 62.6%. 19 manufacturers reported payments, led by Medtronic at 48.0% of the total. Reporting peaked in 2019 at $10,308 and has fallen 96.9% since, to $314 in 2025.
Across 160 payments — averaging $134.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Imperative Care, Inc$7K
- Microvention, Inc.$1K
- Silk Road Medical, Inc.$888
- Rapid Medical Ltd$306
- Stryker$254
- plus $945 from 13 others
Across 40 payments — averaging $3685.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$90K
- Microvention, Inc.$50K
- Sequent Medical, Inc.$7K
What the payments were for
- Consulting fees$13,45063%
- Speaking & faculty fees$3,00014%
- Travel & lodging$2,28111%
- Food & beverage$2,75513%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 46 | $10,320 |
| Imperative Care, Inc | 10 | $7,404 |
| Microvention, Inc. | 24 | $1,369 |
| Silk Road Medical, Inc. | 5 | $888 |
| Rapid Medical Ltd | 11 | $306 |
| Stryker | 8 | $254 |
| Penumbra, Inc. | 24 | $250 |
| Johnson & Johnson(2 entities) | 9 | $152 |
| Asahi Intecc USA, Inc. | 7 | $137 |
| Route 92 Medical, Inc. | 2 | $128 |
| Balt USA, LLC | 5 | $83 |
| Siemens Medical Solutions USA, Inc. | 2 | $32 |
| Contego Medical, Inc | 1 | $31 |
| Scientia Vascular | 1 | $26 |
| AbbVie | 1 | $24 |
| Pfizer | 1 | $22 |
| Viz.ai, Inc. | 1 | $21 |
| W. L. Gore & Associates, Inc. | 1 | $21 |
| Ceribell, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZOOM 88-T LARGE DISTAL PLATFORM$7,283
- Solitaire$6,600
- Covidien-Access$3,000
- WEB$866
- ENROUTE Transcarotid Neuroprotection System$804
- ENROUTE Transcarotid Stent System$804
- ENHANCE Transcarotid Peripheral Access Kit$804
- ENROUTE 0.014 Guidewire$804
- HydroSoft 3D Coil$120
- Sofia$120
- Scepter C Balloon Catheter$120
- 8F Base Camp Sheath System$112
How this compares
$21,486 in reported general payments places this provider in the 80th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $7,643 |
| ClopidogrelClopidogrel Bisulfate | 51 | $320 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $22 | $7,64311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 702 neurology providers in Ohio.
Other neurology in Columbus
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Jacqueline NicholasColumbus$743K
- Geoffrey EubankColumbus$508K
- Jerry MendellColumbus$315K
- Andrew SmithColumbus$254K
- Douglas ScharreColumbus$191K
- Aristide MerolaColumbus$133K
- Miriam FreimerColumbus$105K
- Allison JordanColumbus$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.